Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Poland

 

Orpea restructuring: What will it look to sell?

It has been almost six months since under-fire French nursing home giant Orpea announced plans to get its core business back on track, restructure its debt, and sell around €1.2bn worth of real estate over the next three years. As discussions separating the wheat from the chaff go on behind closed doors, HBI asks three experts where, and what it might sell, and reviews what other French operators like Korian are doing to repair reputation.
May 5, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

TFP up for sale

HBI hears UK-based pan-European fertility group TFP is up for sale, and speaks to two well-placed sources to find out more.
February 10, 2023

Penta buys one for the future in Poland

Czech-Slovak investment group Penta has acquired Polish hospital group Grupa Nowy Szpital (GNS). With this, Penta is making further inroads into the tricky Polish market. HBI asks, given the state of the Polish market, is now really the right time to buy?
December 1, 2022

MidEuropa buys Optegra

UK, Czechia and Poland-based ophthalmology company Optegra has found a buyer - PE firm MidEuropa has reached a definitive agreement to acquire a majority stake while management and current owners H2 will retain minority stakes.
November 29, 2022

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.
November 25, 2022

Scanmed buys Ars Medical

Polish multi-specialty healthcare company Scanmed has bought Polish oncology firm Ars Medical.
November 25, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us